Company news

Haisco Pharmaceutical Group Co. Ltd. Class A (SZSE:002653) news

Haisco Pharmaceutical Group Co. Ltd. Class A news releases on 6ix. Latest, Apr 13, 2026: Haisco Enters into Exclusive License Agreement with AbbVie to Develop…

View Haisco Pharmaceutical Group Co. Ltd. Class A →

Press releases & updates

Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

April 13, 2026

Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion

January 12, 2026